Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Seborrhea Overview 6
Therapeutics Development 7
Pipeline Products for Seborrhea - Overview 7
Seborrhea - Therapeutics under Development by Companies 8
Seborrhea - Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Seborrhea - Products under Development by Companies 12
Seborrhea - Companies Involved in Therapeutics Development 13
Aclaris Therapeutics Inc 13
Amorepacific Corporation 14
Biomar Microbial Technologies 15
EpiPharm AG 16
Phosphagenics Limited 17
Seborrhea - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Drug Profiles 26
artemether - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
hydrogen peroxide - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
IB-07A081 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
IB-07A085 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
ketoconazole - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
PAC-14028 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Seborrhea - Dormant Projects 34
Seborrhea - Discontinued Products 35
Seborrhea - Product Development Milestones 36
Featured News & Press Releases 36
Jul 25, 2016: Aclaris Therapeutics Completes Enrollment of Phase 3 Pivotal Trials of A-101 for the Treatment of Seborrheic Keratosis; Provides Update on Clinical Programs 36
Jan 19, 2016: Aclaris Therapeutics Initiates Phase 3 Clinical Trials of A-101 for the Treatment of Seborrheic Keratosis 36
Mar 17, 2015: Aclaris Therapeutics’ Lead Drug Candidate A-101 Achieves Statistically Significant Results in Third Phase 2 Clinical Trial for Seborrheic Keratosis, a Common Type of Benign Skin Tumor 36
Jan 27, 2015: Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Benign Skin Tumor 37
Jun 30, 2014: Aclaris Therapeutics Announces Positive Results from Phase 2 Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Skin Tumor 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 40
List of Tables
Number of Products under Development for Seborrhea, H2 2016 7
Number of Products under Development by Companies, H2 2016 8
Comparative Analysis by Late Stage Development, H2 2016 9
Comparative Analysis by Clinical Stage Development, H2 2016 10
Comparative Analysis by Early Stage Development, H2 2016 11
Products under Development by Companies, H2 2016 12
Seborrhea - Pipeline by Aclaris Therapeutics Inc, H2 2016 13
Seborrhea - Pipeline by Amorepacific Corporation, H2 2016 14
Seborrhea - Pipeline by Biomar Microbial Technologies, H2 2016 15
Seborrhea - Pipeline by EpiPharm AG, H2 2016 16
Seborrhea - Pipeline by Phosphagenics Limited, H2 2016 17
Assessment by Monotherapy Products, H2 2016 18
Number of Products by Stage and Target, H2 2016 20
Number of Products by Stage and Mechanism of Action, H2 2016 22
Number of Products by Stage and Route of Administration, H2 2016 24
Number of Products by Stage and Molecule Type, H2 2016 25
Seborrhea - Dormant Projects, H2 2016 34
Seborrhea - Discontinued Products, H2 2016 35
List of Figures
Number of Products under Development for Seborrhea, H2 2016 7
Number of Products under Development by Companies, H2 2016 8
Comparative Analysis by Early Stage Products, H2 2016 11
Assessment by Monotherapy Products, H2 2016 18
Number of Products by Targets, H2 2016 19
Number of Products by Stage and Targets, H2 2016 19
Number of Products by Mechanism of Actions, H2 2016 21
Number of Products by Stage and Mechanism of Actions, H2 2016 21
Number of Products by Routes of Administration, H2 2016 23
Number of Products by Stage and Routes of Administration, H2 2016 23
Number of Products by Stage and Molecule Types, H2 2016 25